Epsilon M&A Deal Report - European Pharmaceutical Business of Valeant
Transaction Multiples for the Valuation of Private Companies
Meda / European Pharmaceutical Business of Valeant
No EMAT :
19599
Announced Date :
03/08/2008
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Meda
Target :
European Pharmaceutical Business of Valeant
Country :
Europe
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
The European Pharmaceutical Business of Valeant (WEEMEA) comprises the business operations located in Western Europe, Eastern Europe, Russia, and certain export markets. > WEEMEA discovers,...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
|
|
| Current |
|
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 130
| Date | Acquirer | Target | Country | Multiples | See details |
| 28/10/2008 | Recordati | Yeni Ilaç ve Hammaddeleri San ve Tic | Turkey | ** | 19598 |
| 19/11/2008 | GlaxoSmithKline | AZ Tika | Sweden | * | 19597 |
Source: Epsilon Research / EMAT
